CNCE

Concert Pharmaceuticals, Inc.
CNCE

Overview Fund Activity
Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

79 hedge funds and large institutions have $77M invested in Concert Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-12
Holders Change %
-13.19%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
23
Reduced
31
Closed
26
Calls
$230K
Puts
$161K
Net Calls
+$69K
Net Calls Change
-$293K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
$1.41M
2
ISL
Ingalls & Snyder LLC
New York
$7.3M
3
Millennium Management
Millennium Management
New York
$5.41M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
$1.42M
5
GCP
GSA Capital Partners
United Kingdom
$1.18M

Top Sellers

1
BlackRock
BlackRock
New York
$2.83M
2
SPIA
Steward Partners Investment Advisory
New York
$68K
3
State Street
State Street
Massachusetts
$317K
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
$0
5
Northern Trust
Northern Trust
Illinois
$473K
Name Holding Trade Value Shares
Change 		Shares
Change %
PHK
101
Point72 Hong Kong
Hong Kong
– -$14K -2,870 Closed
AIP
102
Ameritas Investment Partners
Nebraska
– -$12K -2,332 Closed
AIC
103
Ameritas Investment Company
Nebraska
– -$484 -97 Closed
1 2 3 4
5